Aspirin plus clopidogrel for everyone: panacea comes true in the 21st century.
Dangas
G
G
Lenox Hill Heart & Vascular Institute, Cardiovascular Research Foundation, 55 East 59th Street, 6th Floor, New York, NY, USA. gdangas@crf.org
D001241:Aspirin / Q000627:therapeutic use*; D000077144:Clopidogrel; D003328:Coronary Thrombosis / Q000188:drug therapy / Q000517:prevention & control; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000188:drug therapy / Q000517:prevention & control; D019919:Prosthesis Implantation / Q000009:adverse effects; D015607:Stents; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use*
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin